Compare NNBR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNBR | LAB |
|---|---|---|
| Founded | 1980 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 257.2M |
| IPO Year | 1996 | 2008 |
| Metric | NNBR | LAB |
|---|---|---|
| Price | $2.82 | $0.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 965.6K |
| Earning Date | 10-28-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.60 | ★ 61.54 |
| EPS | N/A | ★ 0.29 |
| Revenue | ★ $770,657,000.00 | $101,937,000.00 |
| Revenue This Year | $16.85 | N/A |
| Revenue Next Year | $7.19 | N/A |
| P/E Ratio | ★ N/A | $1.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $0.39 |
| 52 Week High | $4.65 | $1.72 |
| Indicator | NNBR | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.54 | 38.49 |
| Support Level | $2.74 | N/A |
| Resistance Level | $3.06 | $0.79 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 13.16 | 46.65 |
NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.